Related Experiment Video
Updated: Jul 20, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue
Maria G Noval1, Sophie N Spector2, Eric Bartnicki2
1Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA. maria.noval@nyulangone.org.
Insights
Chikungunya virus (CHIKV) infects heart cells, but the immune system usually clears it. However, impaired immunity can cause persistent infection, leading to myocarditis and vascular inflammation, highlighting risks for cardiovascular complications.
Area of Science:
- Cardiovascular Research
- Virology
- Immunology
Background:
- Chikungunya virus (CHIKV) infection is linked to severe cardiac issues.
- The mechanisms behind CHIKV-induced heart disease are not fully understood.
Purpose of the Study:
- To define the mechanisms of CHIKV heart infection.
- To investigate CHIKV's direct impact on cardiac cells and the immune response in the heart.
Main Methods:
- Utilized immunocompetent mouse models and human primary cardiac cells.
- Examined viral replication, host immune response, and cardiac pathology.
- Investigated the role of mitochondrial antiviral-signaling protein (MAVS) in CHIKV clearance.
Main Results:
- CHIKV directly infects and replicates in cardiac fibroblasts.
- In immunocompetent mice, a type I interferon response clears CHIKV without significant cardiac damage.
- MAVS signaling is crucial for viral clearance; its absence leads to persistent infection, myocarditis, and vasculitis of major heart vessels.
- Vasculitis persisted for up to 60 days post-infection.
Conclusions:
- CHIKV infection directly impacts cardiac fibroblasts.
- MAVS-dependent innate immunity is essential for controlling CHIKV in the heart.
- CHIKV can cause long-lasting cardiovascular complications, including myocarditis and vasculitis, emphasizing the need for cardiac monitoring in patients.
Abstract:
Chikungunya virus (CHIKV) infection has been associated with severe cardiac manifestations, yet, how CHIKV infection leads to heart disease remains unknown. Here, we leveraged both mouse models and human primary cardiac cells to define the mechanisms of CHIKV heart infection. Using an immunocompetent mouse model of CHIKV infection as well as human primary cardiac cells, we demonstrate that CHIKV directly infects and actively replicates in cardiac fibroblasts. In immunocompetent mice, CHIKV is cleared from cardiac tissue without significant damage through the induction of a local type I interferon response from both infected and non-infected cardiac cells. Using mice deficient in major innate immunity signaling components, we found that signaling through the mitochondrial antiviral-signaling protein (MAVS) is required for viral clearance from the heart. In the absence of MAVS signaling, persistent infection leads to focal myocarditis and vasculitis of the large vessels attached to the base of the heart. Large vessel vasculitis was observed for up to 60 days post infection, suggesting CHIKV can lead to vascular inflammation and potential long-lasting cardiovascular complications. This study provides a model of CHIKV cardiac infection and mechanistic insight into CHIKV-induced heart disease, underscoring the importance of monitoring cardiac function in patients with CHIKV infections.
Related Concept Videos
Myocarditis III: Medical Management
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease III: Medical Management

